confusion dearrangement
Conditions
Interventions
None listed
Sponsors
GGZ Dijk en Duin (Castricum)
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: All admitted patients will be invited to participate in this study. In order to be eligible to participate, the patient and their legal representative must provide informed consent.
Exclusion criteria
Exclusion criteria: A person who will meet any of the following criteria will be excluded from participation in this study: Isolation because of known carrier ship of a resistant bacterium.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint in this study is *delirium* or *no delirium* classified by the reference standard. The reference or golden standard will be based on the registrations with the camera, which will be evaluated by two or three golden standard specialists, namely geriatricians, psychologists, neurologists or psychiatrists, all with experience in delirium to obtain a reliable diagnosis of the patients using DSM-V criteria. Together with the information from the clinical observational scales and patients* medical files, this will lead to a conclusion on the diagnosis: delirious, non-delirious, or possible delirious. The main study parameters will be the sensitivity, specificity, and predictive values based of each mini EEG in the eyes open and the eyes closed condition (index test) compared to the reference standard (i.e., classification by delirium expert). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study parameters/endpoints (if applicable) i. The association between the output of the EEG monitor and the scores of the observational scales used. ii. Discomfort during mini EEG monitor registration periods. Other study parameters (if applicable) The following characteristics will be collected from the medical chart: i. Age ii. Sex iii. History of neurological or psychiatric disease iv. Psycho-active medication use (including anti-epileptic, anti-psychotics, or benzodiazepines) in the preceding 24 hours. v. Pre-existent cognitive impairment The following characteristics during recording with the EEG monitor will be described: i. Medication use during registration, specifically: psycho-active medication (including benzodiazepines) used in the last 24 hours ii. Number of times that recording with delirium monitor was not feasible and the reason why iii. Current suspected infectious disease, confirmed with positive cultures. | — |
Countries
Netherlands
Outcome results
None listed